Abstract
ABSTRACT: IGF-binding protein-3 (IGFBP-3), usually found as glycosylated 41- and 38-kD forms, is the major serum IGFBP during extrauterine life. In normal serum IGFBP-3 binds one IGF peptide and one acid-labile (α) subunit in a high-molecular-weight (MW) complex of 150 kD. By RIA, an excess of IGFBP-3 is present in chronic renal failure (CRF) serum, where it reportedly accumulates at low MW (25–55 kD) rather than as part of the 150-kD complex. To further evaluate IGFBP-3 forms in CRF, sera were obtained from seven healthy adolescents and seven adolescents with CRF. By RIA, IGFBP-3 levels were higher in CRF than normal sera (15.4 ± 2.2 versus 10.1 ± 2.1 μ g/mL). High-MW (150-kD) fractions of CRF and normal sera, obtained by neutral size-exclusion chromatography, had equal amounts of IGFBP-3 by RIA. However, a second RIA peak of IGFBP-3, present in low-MW (35-kD) fractions of CRF but not normal sera, could account for the higher IGFBP-3 levels of CRF serum. [l25I]IGF ligand blots of whole serum and serum fractions, either with or without prior precipitation by IGFBP-3 antiserum, found levels of 41- and 38-kD IGFBP-3 forms to be similar between CRF and normal whole sera and located these forms in the high-MW (150-kD) fractions of CRF and normal sera. [125I]IGF ligand blots also identified excess IGFBP in low-MW CRF serum fractions; cross-linking these IGFBP with [125I]IGF-I, followed by precipitation with IGFBP-1, -2, and -3 antibodies, identified high levels of unsaturated IGFBP-1, IGFBP-2, and 19- and 14-kD forms of IGFBP-3 in CRF serum. These studies indicate that 1) normal levels of functional 41- and 38-kD IGFBP-3 forms are present in CRF serum, and these forms can be incorporated into the 150-kD serum complex; and 2) high RIA levels of IGFBP-3 in low-MW fractions of CRF serum are at least in part due to 19- and 14-kD IGFBP-3 forms. These studies suggest that the excess unsaturated IGFBP of CRF serum are small enough to enter interstitial tissue spaces where they may modulate IGF-I-mediated mitogenic, metabolic, and differentiative effects.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Powell, D., Liu, F., Baker, B. et al. Characterization of Insulin-Like Growth Factor Binding Protein-3 in Chronic Renal Failure Serum. Pediatr Res 33, 136–143 (1993). https://doi.org/10.1203/00006450-199302000-00011
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1203/00006450-199302000-00011
This article is cited by
-
Growth hormone/insulin-like growth factor system in children with chronic renal failure
Pediatric Nephrology (2005)
-
Modulation of growth factors by growth hormone in children with chronic renal failure
Kidney International (1997)
-
End-organ resistance to growth hormone and IGF-I in epiphyseal chondrocytes of rats with chronic renal failure
Kidney International (1996)
-
Growth promoting effects of growth hormone and IGF-I are additive in experimental uremia
Kidney International (1996)
-
Serum insulin-like growth factors and their binding proteins in children with end-stage renal disease
Pediatric Nephrology (1996)